227.000 PHARMACEUTICAL ADVERTISING

POSITION STATEMENTS

227.000 PHARMACEUTICAL ADVERTISING

227.000      PHARMACEUTICAL ADVERTISING

227.996           Attorney Ads on Drug Side Effects

For attorney commercials that may cause patients to discontinue medically necessary medications, MSSNY, by legislation and/or regulation, will seek to require appropriate warnings that patients should not discontinue medications without seeking the advice of their physician.  MSSNY will introduce a similar resolution to the AMA. (HOD 2016-211)

227.997           Pharmaceutical AdvertisingSUNSET HOD 2020

227.998          Regulation of Media Advertising of Prescription Drugs: SUNSET HOD 2014

227.999          Cost of Drug Disclosure During Direct Advertising:

MSSNY has adopted the position that pharmaceutical companies include in the consumer advertisement of any pharmaceutical the suggested retail price of such pharmaceutical.  (HOD 2001-51; Reaffirmed HOD 2003-252; Reaffirmed HOD 2013; Reaffirmed HOD 2023)

Go to Top